Search

Philip B Komarnitsky

age ~56

from Chestnut Hill, MA

Get Report
Also known as:
  • Philip Komanitsky
  • Phillip S
Phone and address:
175 Eliot St, Boston, MA 02467
(617)9750072
Related to:
Connected to:

Philip Komarnitsky Phones & Addresses

  • 175 Eliot St, Chestnut Hill, MA 02467 • (617)9750072
  • Boston, MA
  • Brookline, MA
  • Antioch, CA
  • Newton, MA
  • Harwich, MA
  • Harwich Port, MA
  • San Francisco, CA
  • Concord, CA
  • 175 Eliot St, Chestnut Hill, MA 02467

Work

  • Company:
    Abbvie
    Jul 2018
  • Position:
    Group medical director

Education

  • Degree:
    Master of Business Administration, Masters
  • School / High School:
    Mit Sloan School of Management
    2002 to 2005

Skills

Clinical Development • Oncology • Biotechnology • Biochemistry • Clinical Research • Clinical Trials • Lifesciences • Biomarkers • Biologics • Medical Devices • Clinical

Languages

English • Russian

Emails

b***[email protected]

Industries

Biotechnology

Resumes

Philip Komarnitsky Photo 1

Brookline, Massachusetts

view source
Location:
175 Eliot St, Chestnut Hill, MA 02467
Industry:
Biotechnology
Work:
Abbvie
Group Medical Director
Abbvie
Senior Medical Director, Oncology Clinical Development
Aveo Oncology Mar 2012 - Dec 2013
Medical Director
Emd Serono, Inc. Mar 2009 - Mar 2012
Medical Director, Oncology
Ziopharm Oncology Jun 2008 - Feb 2009
Associate Medical Director and Senior Director Project Management
Education:
Mit Sloan School of Management 2002 - 2005
Master of Business Administration, Masters University of New Hampshire Sep 1992 - Jun 1997
Doctorates, Doctor of Philosophy, Biochemistry Russian State Medical University 1985 - 1991
Doctor of Medicine, Doctorates, Medicine
Skills:
Clinical Development
Oncology
Biotechnology
Biochemistry
Clinical Research
Clinical Trials
Lifesciences
Biomarkers
Biologics
Medical Devices
Clinical
Languages:
English
Russian

Us Patents

  • Salts Of Isophosphoramide Mustard And Analogs Thereof

    view source
  • US Patent:
    8604007, Dec 10, 2013
  • Filed:
    Apr 4, 2008
  • Appl. No.:
    12/080812
  • Inventors:
    Barbara P. Wallner - Cohasset MA, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
  • Assignee:
    Ziopharm Oncology, Inc. - Charlestown MA
  • International Classification:
    A61K 31/675
  • US Classification:
    514 89, 514 76, 514740, 558199, 564 12
  • Abstract:
    Disclosed herein are crystalline compounds of formula (I).

  • Method For Controlling Angiogenesis In Animals

    view source
  • US Patent:
    20080139629, Jun 12, 2008
  • Filed:
    Sep 28, 2007
  • Appl. No.:
    11/906137
  • Inventors:
    Barbara P. Wallner - Cohasset MA, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
  • Assignee:
    ZIOPHARM Oncology, Inc. - Boston MA
  • International Classification:
    A61K 31/455
    A61K 31/197
    A61P 35/04
  • US Classification:
    514356, 514561
  • Abstract:
    Disclosed are methods for the inhibition of angiogenesis comprising administering an organic arsenical compound.

  • Indibulin Therapy

    view source
  • US Patent:
    20080241274, Oct 2, 2008
  • Filed:
    Nov 27, 2007
  • Appl. No.:
    11/986844
  • Inventors:
    Barbara P. Wallner - Cohasset MA, US
    Brian Eric Schwartz - Woodbridge CT, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
    Gerald Bacher - Germering, DE
    Bernhard Kutscher - Maintal, DE
    Gerhard Raab - Ronneburg, DE
  • Assignee:
    ZIOPHARM Oncology, Inc. - Boston MA
  • International Classification:
    A61K 33/24
    A61K 31/4439
    A61K 31/517
    A61K 31/7048
    A61P 35/00
    A61K 31/56
    A61K 31/704
    A61K 31/505
  • US Classification:
    424649, 514339, 5142664, 514274, 514 34, 514 27, 514178
  • Abstract:
    The invention provides combination therapy, wherein one or more other therapeutic agents are administered with indibulin or a pharmaceutically acceptable salt thereof and the combination is synergistic. Another aspect of the invention relates to the treatment of cancer with indibulin as a single agent. Another aspect of the invention relates to dosing regimen for administration of oral dosage forms of indibulin.

  • Combination Therapy With Organic Arsenicals

    view source
  • US Patent:
    20100311689, Dec 9, 2010
  • Filed:
    Oct 31, 2008
  • Appl. No.:
    12/740661
  • Inventors:
    Barbara P. Wallner - Cohasset MA, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
  • Assignee:
    ZIOPHARM Oncology, Inc - Boston MA
  • International Classification:
    A61K 31/285
    A61K 31/44
    A61K 31/513
    A61K 31/4745
    A61K 31/573
    A61K 31/69
    A61P 35/00
  • US Classification:
    514 64, 514350, 514274, 514504, 514283, 514171
  • Abstract:
    The invention provides a combination therapy wherein one or more other therapeutic agents are administered with an organic arsenical, preferably SGLU-1 or a pharmaceutically acceptable salt thereof. The invention also relates to methods for the treatment of cancer, comprising administering SGLU-1 in combination with another therapeutic agent. Another aspect of the invention relates to a kit comprising SGLU-1 and another therapeutic agent.

  • Organoarsenic Compounds And Methods For The Treatment Of Cancer

    view source
  • US Patent:
    20110269697, Nov 3, 2011
  • Filed:
    Aug 14, 2009
  • Appl. No.:
    13/059176
  • Inventors:
    Brian Eric Schwartz - Woodbridge CT, US
    Jonathan Lewis - Fairfield CT, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
  • International Classification:
    A61K 38/06
    C07F 9/72
    A61P 35/00
    C07K 5/083
    A61K 31/555
    C07F 9/82
    A61K 31/285
    A61K 31/60
  • US Classification:
    514 193, 514504, 556 70, 514159, 530331, 514188, 546 3
  • Abstract:
    A method for treating a lymphoma selected from non-Hodgkin's and Hodgkin's lymphoma comprising administering an organoarsenic compound having a structure of the formula (I) wherein X is S or Se and Rand Rare independently Calkyl(R, R, R, R, W and “n” are as defined in claim ) in particular where the compound is S-dimethylarsinoglutathione, N-(2-S-dimethylarsinothiopropionyl)glycine, 2-amino-3-(dimethylarsino)thio-3-methylbutanoic acid, S-dimethylarsino-thiosuccinic acid or S-dipropylarsino--thioglycerol.

  • Combination Therapy With Organic Arsenicals

    view source
  • US Patent:
    20120295861, Nov 22, 2012
  • Filed:
    Jul 26, 2012
  • Appl. No.:
    13/559036
  • Inventors:
    Barbara P. WALLNER - Cohasset MA, US
    Philip B. KOMARNITSKY - Chestnut Hill MA, US
  • Assignee:
    ZIOPHARM ONCOLOGY, INC. - Boston MA
  • International Classification:
    A61K 31/285
    A61K 31/573
    A61K 31/4745
    A61K 31/704
    A61K 31/44
    A61P 35/00
    A61P 35/02
    A61K 31/69
    A61K 31/513
  • US Classification:
    514 34, 514504, 514 64, 514171, 514283, 514274, 514350
  • Abstract:
    The invention provides a combination therapy wherein one or more other therapeutic agents are administered with an organic arsenical, preferably SGLU-I or a pharmaceutically acceptable salt thereof. The invention also relates to methods for the treatment of cancer, comprising administering SGLU-I in combination with another therapeutic agent. Another aspect of the invention relates to a kit comprising SGLU-I and another therapeutic agent.

  • Indibulin Therapy

    view source
  • US Patent:
    20130084345, Apr 4, 2013
  • Filed:
    Nov 20, 2012
  • Appl. No.:
    13/681828
  • Inventors:
    Brian Eric Schwartz - Woodbridge CT, US
    Philip B. Komarnitsky - Chestnut Hill MA, US
    Gerald Bacher - Germering, DE
    Bernhard Kutscher - Maintal, DE
    Gerhard Raab - Ronneburg, DE
  • Assignee:
    ZIOPHARM ONCOLOGY, INC. - Boston MA
  • International Classification:
    A61K 31/4439
    A61K 31/513
    A61K 45/06
    A61K 31/7068
    A61K 31/573
    A61K 33/24
    A61K 31/565
    A61K 31/704
    A61K 31/475
    A61K 31/7048
    A61K 31/517
    A61K 31/437
  • US Classification:
    424649, 514339, 5142664, 514274, 514 49, 514280, 514171, 514 34, 514282, 514 27
  • Abstract:
    The invention provides combination therapy, wherein one or more other therapeutic agents are administered with indibulin or a pharmaceutically acceptable salt thereof and the combination is synergistic. Another aspect of the invention relates to the treatment of cancer with indibulin as a single agent. Another aspect of the invention relates to dosing regimen for administration of oral dosage forms of indibulin.

  • Combination Therapy With Organic Arsenicals

    view source
  • US Patent:
    20130261082, Oct 3, 2013
  • Filed:
    Mar 6, 2013
  • Appl. No.:
    13/786591
  • Inventors:
    Philip B. KOMARNITSKY - Chestnut Hill MA, US
  • Assignee:
    ZIOPHARM ONCOLOGY, INC. - Boston MA
  • International Classification:
    A61K 31/285
    A61K 31/69
    A61K 31/44
    A61K 31/4745
    A61K 31/513
    A61K 31/282
    A61K 31/573
  • US Classification:
    514 64, 514171, 514283, 514504, 514274, 514346
  • Abstract:
    The invention provides a combination therapy wherein one or more other therapeutic agents are administered with an organic arsenical, preferably SGLU-I or a pharmaceutically acceptable salt thereof. The invention also relates to methods for the treatment of cancer, comprising administering SGLU-I in combination with another therapeutic agent. Another aspect of the invention relates to a kit comprising SGLU-I and another therapeutic agent.

Youtube

Poetry: From Pulitzer to Performance

Poetry: From Pulitzer to Performance

Nationally-accla... poets Philip Levine and Ken Arkind share their wo...

  • Duration:
    57m 30s

Philip Glass (arr. Michael Riesman and Nico M...

Philip Glass (arr. Michael Riesman and Nico Mhly) ...

Philip Glass (1937-) needs no introduction from me. This is the publis...

  • Duration:
    3m 34s

Stanford Seminar - Interactive Systems for Le...

Stanford Seminar - Interactive Systems for Learnin...

Philip Guo University of Rochester This seminar series features dynami...

  • Duration:
    1h 7m 38s

Art'n'Voices feat. Leszek Moder - Lully, Lull...

Art'n'Voices feat. Leszek Moder - Lully, Lulla, Lu...

Art'n'Voices - Lully, Lulla, Lullay by Philip Stopford performed with ...

  • Duration:
    5m 22s

PHILIPS VINGBOOKS & HERMANN HOUSE | ICARCH 2022

PHILIPS VINGBOOKS & HERMANN HOUSE | ICARCH 2022

International Conversations about Architecture A series of online lect...

  • Duration:
    30m 6s

Innovations in Sculpture and the Status of Ar...

Innovations in Sculpture and the Status of Artists...

Learn more about the exhibition The Mourners: Medieval Tomb Sculptures...

  • Duration:
    43m 45s

Mozart's Violin Comes to the U.S. for the Fir...

Mozart's Violin Comes to the U.S. for the First Ti...

On June 14, 2013, Fulmer performed the Mozart violin sonata, as well a...

  • Duration:
    2m 44s

2021 Symposium: Developments in Environmental...

2021 Symposium: Developments in Environmentally Co...

The London Alternative Photography Collective and The Sustainable Dark...

  • Duration:
    3h 15m 5s
Get Report for Philip B Komarnitsky from Chestnut Hill, MA, age ~56
Control profile